Protecting Seniors Through Immunization Act of 2021 This bill specifies that certain deductible, coinsurance, initial coverage limit, and cost-sharing requirements that apply under the Medicare prescription drug benefit shall not apply with respect to vaccines that are recommended by the Advisory Committee on Immunization Practices of the Centers for Disease Control and Prevention. The Centers for Medicare & Medicaid Services must provide to Medicare beneficiaries specified information regarding (1) coverage of vaccines for seniors, and (2) access to recommended vaccines without cost-sharing.
Data to Save Moms Act This bill expands data collection and research on maternal morbidity and mortality among minority populations. Specifically, the bill adds requirements to a program within the Centers for Disease Control and Prevention (CDC) that supports maternal mortality review committees. To the extent practicable, the committees must use the most up-to-date indicators of severe maternal morbidity; review deaths caused by suicide, overdose, or other behavioral health conditions attributed to or aggravated by pregnancy or childbirth; and consult with representatives of communities about nonclinical factors that may contribute to adverse maternal outcomes. The CDC may also award grants to committees to increase their engagement with local communities, such as by bringing on community representatives as committee members. Additionally, the Centers for Medicare & Medicaid Services and the Agency for Healthcare Research and Quality must consult with diverse stakeholders to review maternal health data collection processes and quality measures and make recommendations to improve them. The Indian Health Service and the Department of Health and Human Services must also arrange for studies on adverse maternal health outcomes among tribal and minority populations, respectively.
Chai Suthammanont Remembrance Act of 2021 This bill requires federal agencies to develop and disclose safety plans that contain certain information for on-site employees and contractors during the public health emergency relating to COVID-19 (i.e., coronavirus disease 2019). Specifically, the bill requires each agency to post a safety plan on its website that includes descriptions of (1) the personal protective equipment that the agency will provide to its on-site employees and contractors; (2) protections for employees whose work requires them to travel off-site; (3) testing, contact-tracing, and vaccination protocols; and (4) protocols that ensure the continuity of operations in the event it is necessary to reverse on-site requirements. Each agency's Office of the Inspector General must report on whether the agency has published and implemented its safety plan.
Stopping the Pharmaceutical Industry from Keeping drugs Expensive Act or the SPIKE Act This bill requires the Centers for Medicare & Medicaid Services (CMS) to determine at least annually whether certain covered drugs under Medicare were subject to a price increase that exceeded specified thresholds. Drug manufacturers must submit justifications for such price increases to the CMS, subject to civil penalties. The bill's requirements do not apply to low-cost drugs, as identified by the CMS.
Cancer Care Planning and Communications Act of 2021 This bill provides for Medicare coverage and payment of cancer care planning and coordination services for individuals who are diagnosed with or treated for cancer, including the development of treatment plans, follow-up care, and any necessary revisions.
This bill reauthorizes through FY2022 and otherwise revises the Centers for Disease Control and Prevention (CDC) national awareness campaign regarding gynecologic cancers. The CDC must target specified populations of women at higher risk for gynecologic cancers in the campaign. Additionally, the CDC may establish a grant program to evaluate different strategies to increase knowledge and awareness of gynecologic cancers among women and health care providers. In awarding these grants, the CDC must give preference to (1) grantees with expertise in gynecologic cancer education or treatment or expertise in working with groups of women at increased risk of such cancers; and (2) projects that will establish links between health care providers, hospitals, insurance companies, and state health departments.
Veterans Preventive Health Coverage Fairness Act This bill eliminates veterans' copayments for medication, hospital care, and medical services related to preventive health services provided by the Department of Veterans Affairs. The bill expands the definition of preventive health services to include (1) evidence-based items or services that have an A or B rating in the recommendations of the United States Preventive Services Task Force; (2) immunizations that have a recommendation from the Advisory Committee on Immunization Practices of the Centers for Disease Control and Prevention with respect to the individual involved; and (3) with respect to women, the preventive care and screenings provided for in the Health Resources and Services Administration Preventive Services Guidelines in effect as of January 1, 2017.
Fairly Assessing Service-related Toxic Exposure Residuals Presumptions Act or the FASTER Presumptions Act This bill revises policies and procedures of the Department of Veterans Affairs (VA) related to establishing or modifying presumptions of service-connection based on toxic exposure. The bill sets up a procedure by which the VA must determine whether to establish, remove, or modify via regulations presumptions of service-connection based on toxic exposure. Specifically, the bill establishes within the VA the Formal Advisory Committee on Toxic Exposure, the Science Review Board, and the Working Group to assist with the various procedures in establishing or removing presumptions of service-connection. Such procedures include assessing the exposure of veterans to toxic substances during active service, evaluating research on the health effects of exposure, and making recommendations based on the evidence and research. The bill also establishes the Expert Advisory Panel on Constrictive Bronchiolitis within the VA to develop guidelines for VA research on symptomatic veterans who served on active duty in the Southwest Asia theater of operations and have bronchiolitis. The Department of Defense must develop and implement a plan to strengthen data collection with respect to members of the Armed Forces (including the reserve components) who are exposed to toxic substances while serving. The VA must initiate or sponsor various studies related to veterans who served on active duty in certain locations. Finally, the VA must provide annual training to relevant employees to improve the handling of claims for compensation and benefits that relate to toxic exposure.
Dispose Unused Medications and Prescription Opioids Act or the DUMP Opioids Act This bill requires the Department of Veterans Affairs (VA) to ensure that each VA medical facility with an on-site pharmacy or a physical location dedicated for law enforcement purposes has a physical location where any individual may dispose of controlled substances medications.
Access to Assistive Technology and Devices for Americans Study Act or the Triple A Study Act This bill directs the Government Accountability Office (GAO) to study issues related to health insurance and other coverage for assistive technologies, such as prosthetic devices and custom orthoses, for those who experience amputations or live with a limb difference. In conducting this study, the GAO must include comparisons of claims and other data from Medicare, the Department of Veterans Affairs, and commercial health insurers.
Veterans Burn Pits Exposure Recognition Act of 2021 This bill requires the Department of Veterans Affairs (VA) to concede, for the purposes of health care benefits and wartime disability compensation, that a veteran was exposed to certain toxic substances, chemicals, and hazards from burn pits if such veteran served on active duty in a covered location during a specified time frame (unless there is affirmative evidence to establish that the veteran was not exposed during such service). A burn pit is an area used for burning solid waste in open air without equipment. Specifically, the bill covers the following locations and corresponding time periods: Iraq between August 2, 1990, and February 28, 1991, as well as from March 19, 2003, until burn pits are no longer used in this location; Somalia and Southwest Asia (including Kuwait, Saudi Arabia, Oman, and Qatar) from August 2, 1990, until burn pits are no longer used in these locations; and Afghanistan, Syria, Jordan, Egypt, Lebanon, Yemen, Uzbekistan, the Philippines, and Djibouti from September 11, 2001, until burn pits are no longer used in these locations. Under the bill, if an exposed veteran submits insufficient evidence to establish a service-connection for purposes of disability compensation, the VA shall provide a medical examination and request a medical opinion regarding a causal link between the disability and a toxin, chemical, or hazard.
This resolution recognizes and expresses support for the efforts of democracy and human rights activists in Cuba.
